ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: GlobeNewswire
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. SO WHAT: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Maravai class action, go to https://rosenlegal.com/submit-form/?case_id=36259 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 5, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing th
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Maravai LifeSciences (NASDAQ:MRVI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.MarketBeat
- Why Analysts See Opportunity and Risk as Maravai's Story Evolves After Management Shakeup [Yahoo! Finance]Yahoo! Finance
- CEO & Director of Maravai LifeSciences Holdings Picks Up 13% More Stock [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Announces November 2025 Investor Conference ScheduleBusiness Wire
- Maravai LifeSciences Reports Third Quarter 2025 Financial ResultsBusiness Wire
MRVI
Earnings
- 11/6/25 - In-Line
MRVI
Sec Filings
- 12/19/25 - Form 144
- 12/9/25 - Form 4
- 11/18/25 - Form 4
- MRVI's page on the SEC website